US News & World Report: Immunotherapy and cancer, COVID-19
July 21, 2020
National media outlets report on new UC findings that show immunotherapy will not worsen complications for patients who have cancer and COVID-19.
July 21, 2020
National media outlets report on new UC findings that show immunotherapy will not worsen complications for patients who have cancer and COVID-19.
September 22, 2020
Drugs.com covers UC research looking at mortality in patients with cancer and COVID-19.
September 22, 2020
WVXU reports on a University of Cincinnati study showing cancer patients undergoing a combination of chemotherapy and immunotherapy one to three months before a COVID-19 diagnosis have a greater risk of death than patients who haven't undergone cancer treatment in the past year.
August 6, 2020
During a pandemic, cancer is all the more terrifying, uncertain, and lonely. UC Cancer Center researchers weigh in.
July 9, 2020
UC's Trisha Wise-Draper, MD, PhD, has been named one of InStyle Magazine's "Badass 50" health care providers making a difference during the pandemic.
November 25, 2024
A growing body of evidence suggests those in the low- and middle-income brackets are more likely to develop long COVID-19, to suffer longer with its symptoms and to endure job loss, eviction and other serious consequences because of it.
August 11, 2021
Researchers at the University of Cincinnati College of Medicine have developed a computerized decision analytic model to compare projected outcomes of three vaccine strategies: a patient opts for a messenger RNA vaccine, a patient decides to get an adenovirus vector vaccine or the patient simply forgoes a vaccine altogether.
August 27, 2021
The school year rapidly approaches amid a surge in pediatric COVID-19 hospitalizations, and parents desperately want to know: When can young children get the vaccine? UC's Carl Fichtenbaum weighs in.
November 29, 2021
Over the Thanksgiving weekend, the World Health Organization gave the name omicron to the newest identified version of SARS-CoV-2 and called it a variant of concern. There is still much to be learned about this latest variant and how potentially dangerous it is. In a story on the variant, Cincinnati.com interview Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.